137 related articles for article (PubMed ID: 8077054)
1. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C.
Xu BH; Gupta V; Singh SV
Int J Cancer; 1994 Sep; 58(5):686-92. PubMed ID: 8077054
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
Singh SV; Scalamogna D; Xia H; O'Toole S; Roy D; Emerson EO; Gupta V; Zaren HA
Int J Cancer; 1996 Mar; 65(6):852-7. PubMed ID: 8631603
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP
Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a BMS-181174-resistant human bladder cancer cell line.
Xia H; Bleicher RJ; Hu X; Srivastava SK; Gupta V; Zaren HA; Singh SV
Br J Cancer; 1997; 76(4):461-6. PubMed ID: 9275022
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.
Xu BH; Gupta V; Singh SV
Br J Cancer; 1994 Feb; 69(2):242-6. PubMed ID: 8297721
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line].
Xu B; Sun Y; Singh SV
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):343-6. PubMed ID: 8697971
[TBL] [Abstract][Full Text] [Related]
9. Biochemical mechanism of cross-resistance to paclitaxel in a mitomycin c-resistant human bladder cancer cell line.
Bleicher RJ; Xia H; Zaren HA; Singh SV
Cancer Lett; 2000 Mar; 150(2):129-35. PubMed ID: 10704734
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line.
Xia H; Bleicher RJ; Gupta V; Zaren HA; Singh SV
Int J Cancer; 1997 Mar; 70(5):606-11. PubMed ID: 9052763
[TBL] [Abstract][Full Text] [Related]
11. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
Lambert PA; Kang Y; Greaves B; Perry RR
J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
[TBL] [Abstract][Full Text] [Related]
12. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
Xu BH; Singh SV
Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
[TBL] [Abstract][Full Text] [Related]
13. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid.
Singh SV; Xu BH; Maurya AK; Mian AM
Biochim Biophys Acta; 1992 Nov; 1137(3):257-63. PubMed ID: 1445927
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
Lee JH; Naito M; Nakajima M; Tsuruo T
Cancer Chemother Pharmacol; 1993; 33(3):215-20. PubMed ID: 7505723
[TBL] [Abstract][Full Text] [Related]
15. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
O'Dwyer PJ; Perez RP; Yao KS; Godwin AK; Hamilton TC
Biochem Pharmacol; 1996 Jul; 52(1):21-7. PubMed ID: 8678904
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of a mitomycin C resistant colon cancer cell line variant.
Perry RR; Kang Y; Greaves B
Biochem Pharmacol; 1993 Dec; 46(11):1999-2005. PubMed ID: 7903534
[TBL] [Abstract][Full Text] [Related]
17. Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions.
Hoban PR; Walton MI; Robson CN; Godden J; Stratford IJ; Workman P; Harris AL; Hickson ID
Cancer Res; 1990 Aug; 50(15):4692-7. PubMed ID: 2114946
[TBL] [Abstract][Full Text] [Related]
18. Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin-resistant bladder cancer cell-line model.
French AJ; Datta SN; Allman R; Matthews PN
BJU Int; 2004 Jan; 93(1):156-61. PubMed ID: 14678389
[TBL] [Abstract][Full Text] [Related]
19. Contrasting molecular cytotoxic mechanisms of mitomycin C and its two analogs, BMY 25282 and BMY 25067, in isolated rat hepatocytes.
Silva JM; Khan S; O'Brien PJ
Biochem Pharmacol; 1993 Jun; 45(11):2303-9. PubMed ID: 8517871
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
Perry RR; Greaves BR; Rasberry U; Barranco SC
Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
